Sohier Yahia | Genetics and Metabolic | Women Researcher Award

Prof. Sohier Yahia | Genetics and Metabolic | Women Researcher Award

Faculty Of Medicine- Mansoura University | Egypt

PUBLICATION PROFILE

Google Scholar

EARLY ACADEMIC PURSUITS 🎓

Prof. Sohier Yahia’s academic journey began with a distinguished undergraduate education at Mansoura University, where she earned her M.B.B.CH. degree with honors in November 1993. This strong foundation in medicine was followed by a specialization in pediatrics, culminating in her M.Sc. in Pediatrics in November 1998 and her M.D. in Pediatrics in November 2002. These achievements underscore her commitment to excellence in the medical field from the outset of her career.

PROFESSIONAL ENDEAVORS 💼

Throughout her career, Prof. Yahia has played a pivotal role in shaping the field of pediatrics and genetics. As the Head of the Genetics and Metabolic Unit at Mansoura University Children’s Hospital since March 2022, she leads critical advancements in pediatric genetics. Her long tenure as a professor, assistant professor, and lecturer at the Faculty of Medicine, Mansoura University, reflects her dedication to teaching and mentoring future generations of medical professionals. Her clinical expertise spans a wide range of pediatric subspecialties, including genetics, neurology, cardiology, neonatology, and more. She has also been a consultant in pediatric genetics and metabolic disorders, providing care for children with complex medical needs.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Prof. Yahia’s research has focused primarily on genetic factors influencing pediatric health, with notable theses on “Genetic Factors Predisposing Children to Develop Hypertension” and “Molecular Genetic Markers in Childhood Leukemias.” These topics are crucial for advancing diagnostic methods and treatment strategies for pediatric diseases. Her contributions to the field extend beyond research; she has been instrumental in editing textbooks on medical genetics, pediatrics, and clinical management, thereby influencing medical education on a broader scale.

IMPACT AND INFLUENCE 🌍

Prof. Yahia’s work has made a profound impact not only on her immediate academic and clinical environments but also globally. Her participation in international conferences and workshops, such as those in Egypt, Morocco, Brazil, and Turkey, showcases her leadership in pediatric genetics and metabolic disorders. As an instructor in numerous workshops, she has disseminated knowledge on molecular biology, genetic counseling, and pediatric care. This cross-border influence cements her role as a key figure in the global medical community.

ACADEMIC CITATIONS 📚

Prof. Yahia has contributed to numerous academic works, including chapters in books and editing roles in publications related to pediatric genetics, metabolic disorders, and neonatal screening programs. These contributions have been cited in academic circles and have provided a vital resource for medical practitioners, researchers, and students worldwide. Her work has earned her recognition as an authority in pediatric genetics, enhancing her visibility in academic literature.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

As a professor and researcher, Prof. Yahia’s legacy is already solidified through her numerous roles in shaping medical education, clinical practices, and genetic research. Looking to the future, her continued involvement in cutting-edge research and medical education will likely pave the way for further advancements in pediatric healthcare, particularly in the diagnosis and treatment of genetic disorders. Her ongoing training in crisis management, leadership, and strategic decision-making, as well as her role in national security courses, further broadens her impact, preparing her to address the challenges of tomorrow’s healthcare systems.

INTERNATIONAL ENGAGEMENT AND NETWORKING 🌐

Prof. Yahia’s involvement in international conferences and workshops has strengthened her network within the global medical community. She has been a speaker, chairperson, and attendee at a variety of prestigious events, including the International Delta Pediatric Conference and the 5th MPS Masterclass. These opportunities have not only allowed her to share her knowledge but also stay at the forefront of global developments in pediatric genetics and healthcare, ensuring that her work remains relevant and influential.

WORKSHOPS AND TRAINING 📈

In addition to her clinical and academic roles, Prof. Yahia has contributed significantly to the professional development of healthcare providers through her leadership in workshops and training courses. These include courses on molecular diagnosis, genetic counseling, and pediatric care management. Her role as an instructor in several high-profile workshops attests to her commitment to fostering knowledge and skills in the next generation of healthcare providers.

SCIENTIFIC EXPERIENCE AND RESEARCH IMPACT 🔍

Prof. Yahia’s research into genetic predispositions in childhood hypertension and molecular markers in leukemia has laid the groundwork for critical advancements in personalized medicine for pediatric patients. Her scientific experience and dedication to these fields have provided insights that are vital for improving treatment options and outcomes for children affected by genetic disorders. This ongoing focus on research and evidence-based practices ensures her work remains at the cutting edge of pediatric genetics and medicine.

FUTURE VISION 🌟

With her robust background in medical education, clinical practice, and research, Prof. Yahia is poised to continue making significant contributions to pediatric healthcare, particularly in genetics and metabolic diseases. Her leadership in developing new medical curricula and her participation in international workshops will inspire and guide future professionals. Her ongoing commitment to advancing healthcare policies and practices further underscores her dedication to leaving a lasting legacy in the field of pediatric medicine.

 TOP NOTES PUBLICATIONS 📚

Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.

Authors: DAM Mansour AK, Aly RM, Abdelrazek SY, Elghannam DM, Abdelaziz SM, Shahine …
Journal: Hematol Oncol Stem Cell
Year: 2012
Volume: 5 (1), 54-59

 Increased DNA damage in children caused by passive smoking as assessed by comet assay and oxidative stress.

Authors: A Zalata, S Yahia, A El-Bakary, HM Elsheikha
Journal: Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Year: 2007
Volume: 629 (2), 88

Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants.

Authors: S Yahia, AE Shabaan, M Gouida, D El-Ghanam, H Eldegla, A El-Bakary
Journal: European Journal of Pediatrics
Year: 2015
Volume: 174, 459-464

Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study.

Authors: S Yahia, MA El-Hadidy, AH El-Gilany, R Anwar, A Darwish, AK Mansour
Journal: International Journal of Hematology
Year: 2013
Volume: 97, 604-609

Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.

Authors: A Hammad, YM Mosaad, EM Hammad, S Elhanbly, SR El-Bassiony, …
Journal: Autoimmunity
Year: 2016
Volume: 49 (1), 31-40

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Åbo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

💼 Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

📖Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu at Clinton health Access Initiative, Cameroon

👨‍🎓 Professional Profile

🌟 Current Position

Dr. Yauba Saidu serves as the Project Coordinator for the Building a National Medical Oxygen Strategy for Cape Verde and is also the Founder and President of the One Health Pastoral Initiative. In addition, he coordinates projects focused on strengthening human resources for health in the Central African Republic and protects chemotherapy drug quality in sub-Saharan Africa.

🎓 Early Academic Pursuits

Dr. Saidu earned his MD in General Medicine in 2007, followed by an MSc in Vaccinology and Pharmaceutical Clinical Development in 2011. He continued to enhance his expertise with a Ph.D. in Life Sciences (Global Health option) in 2023, and he recently completed a Certificate Program in One Health from the University of Florida in 2024.

💼 Professional Endeavors

Dr. Saidu’s career spans multiple high-impact roles in public health. Since 2021, he has been the Country Director for the Clinton Health Access Initiative in Cameroon, alongside his role as the National Coordinator for The Lancet NCDI Poverty Commission. His experience also includes significant positions at the Medical Research Council Unit in The Gambia and various roles in the Clinton Health Access Initiative, where he contributed to numerous health programs.

🔬 Contributions and Research Focus

With over 75 research papers and 2 book chapters to his name, Dr. Saidu has made significant contributions to global health, particularly in areas such as immunization services, chemotherapy drug quality, and public health strategies. His research emphasizes the intersection of health systems and the impact of non-communicable diseases in resource-limited settings.

🌍 Impact and Influence

Dr. Saidu’s work has garnered recognition, including his designation as a Knight of the Cameroon Order of Valor in 2022. His leadership in various health initiatives has had a profound impact on health outcomes in Cameroon and across sub-Saharan Africa.

📚 Academic Cites

His research has received over 470 citations, achieving an H-index of 10, reflecting his influence in the field. His notable publications include contributions to vaccinology and climate change and health system sustainability.

🛠️ Technical Skills

Dr. Saidu possesses a diverse set of technical skills, including program management, clinical trial coordination, and expertise in vaccinology and public health policy. His ability to navigate complex health systems and drive initiatives for improved health access is a hallmark of his career.

👨‍🏫 Teaching Experience

As a student supervisor at the University of Buea, Dr. Saidu actively mentors the next generation of healthcare professionals, imparting his knowledge and experience in global health challenges.

🕊️ Legacy and Future Contributions

Dr. Saidu’s commitment to improving health outcomes in Africa positions him as a pivotal figure in global health. His ongoing projects aim to strengthen healthcare systems, expand access to essential medicines, and address the unique health challenges faced by vulnerable populations. As he continues to drive impactful health initiatives, Dr. Saidu is poised to leave a lasting legacy in the field of global health.

 

📖 Top Noted Publications

 Anticipating and strategizing to address potential bottlenecks during clinical research projects in sub-Saharan Africa: a case for adapting approaches and tools used in the entrepreneurial and development sectors

Authors: Saidu, Y., Nchinjoh, S.C., Adidja, A., Ndom, P., Liebermann, M.
Journal: Trials
Year: 2024

Functional availability of medical oxygen for the management of hypoxaemia in Cameroon: A nationwide facility-based cross-sectional survey

Authors: Saidu, Y., Ndip, A.V., Diaby, O., Balkissou, A.D., Wiwa, O.
Journal: Journal of Global Health
Year: 2024

Climate change in Africa case studies: Role of healthcare and sustainable interventions

Authors: Umesi, A., Ubiame, O., Saidu, Y., Paul Jaiyeola, O., Darkwah, A.F.
Journal: Routledge Handbook of Climate Change and Health System Sustainability
Year: 2024

COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness

Authors: Wariri, O., Afolabi, M.O., Mukandavire, C., Uthman, O.A., Kampmann, B.
Journal: BMJ Global Health
Year: 2023

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon’s Expanded program on Immunization

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: Human Resources for Health
Year: 2023

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: BMC Health Services Research
Year: 2023

 Beyond the numbers: An in-depth look at Cameroon’s fifth national COVID-19 vaccination campaign through geographical and gender lenses

Authors: Amani, A., Njoh, A.A., Atuhebwe, P., Chaiban, T., Gueye, A.S.
Journal: Vaccine
Year: 2023